octreotide (Aegis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameoctreotide (Aegis)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAegis Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAegis Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsAcromegaly

Other Information

ATC CodeN/A
Related LinksN/A